EXCLUSIVE: Top doctor Dr Kim Boyd says its programmes are needed 'more than ever' despite the boom in weight loss drugs.

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

A new drug prevents weight gain and fatty liver by controlling magnesium in cells. It made mice stay slim despite lifelong ...

Fatty liver disease affects more than 1 in 3 adults and often has no symptoms. A new drug developed with Tulane researchers ...